Metastatic stage IV HER2 positive adenocarcinoma of the stomach or gastro-oesophageal junction Initial PBS Authority application Supporting information form (PB173)

You must lodge this form for a patient starting initial Pharmaceutical Benefits Scheme (PBS) subsidised treatment with trastuzumab for metastatic stage IV Human Epidermal Growth Factor Receptor 2 (HER2) positive adenocarcinoma of the stomach or gastrooesophageal junction.

 

Page last updated: 5 February 2016

This information was printed Tuesday 27 September 2016 from humanservices.gov.au/health-professionals/forms/pb173 It may not include all of the relevant information on this topic. Please consider any relevant site notices at humanservices.gov.au/siteinformation when using this material.